Low Back Pain and Chiropractic Care

swript low back pain

A Middle-Aged Nurse Dies during Botched Treatment of Back Pain In August 2018, a 44-year-old registered urgent care nurse who had been diagnosed with chronic back pain died in a suspected case of unintentional (non-suicide) lethal drug overdose, which was…

COVID-19 – From Recognition of SARS-CoV-2 to Understanding the Lifecycle of the Virus

Mutations of pathogenic strains of SARS-CoV-2 reveal that the virus is undergoing homologous recombination inside the human body. This provides an opportunity to use genetically-modified SARS-CoV-2, which can be introduced into the human respiratory tract through viral nanoparticles, to reduce severity of new infections. The genome of the genetically-engineered SARS-CoV-2 RNA can be tweaked to encode defective HE and S proteins (or even encode antiviral proteins). This genome can also be stripped off the genes that encode the S glycoprotein. If this bio-engineered virus is introduced into the respiratory tract of an infected person, then it can exchange genetic material via homologous recombination with the wild-type/pathogenic SARS-CoV-2 virus, and this homologous recombination allows for new viruses formed to be non-infective or non-pathogenic or have reduced pathogenecity. This homologous recombination can cause a loss of function mutation in the next-generation of SARS-CoV-2 virus, and if the sub-strain affected is the L-type SARS-CoV-2, then the severity of COVID-19 can be reduced and disease progression suppressed.